This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Questcor Partners With National Kidney Foundation As National Sponsor Of Kidney Walk

HAYWARD, Calif., April 17, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it is partnering with the National Kidney Foundation (NKF) to become a National Sponsor of Kidney Walk, the country's largest walk to raise money and awareness for kidney disease.

Through this partnership, Questcor will support more than 85 Kidney Walks across the country.  The nationwide series is comprised of community events that call attention to kidney disease and the need for organ donation. More than 100,000 walkers, 6,000 teams and 300,000 donors raise more than $8 million dollars annually to support the NKF's local awareness, prevention and treatment programs.

"Questcor is very pleased to partner with the National Kidney Foundation as a National Corporate Sponsor of Kidney Walk," said Steve Cartt, Questcor's Chief Operating Officer.  "As a company, we are committed to serving the needs of kidney patients, their families and the healthcare providers who care for them.  Our support of the Kidney Walk helps the Foundation serve its mission to raise awareness of kidney disease and to provide lifesaving programs that directly impact kidney patients and their families."

According to NKF, kidney disease annually kills more people than breast and prostate cancer combined. One in three American adults — 73 million — is at risk due to high blood pressure, diabetes or a family history of kidney failure. More than 26 million people in the U.S. already have kidney disease and most don't know it.

"The Kidney Walk is not only a fundraiser, but a tool to generate awareness and drive prevention in major cities and communities throughout the U.S.," said Krystn Kuckelman, the National Walk Program Director. "Questcor's support will help us reach the millions who are at risk of developing kidney disease."

Mr. Cartt added, "The NKF is on the front lines when it comes to raising awareness of kidney disease and advocating for kidney patients.  Questcor is very proud to support this effort as well as other important initiatives of NKF."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,731.18 +100.91 0.57%
S&P 500 2,105.00 +11.75 0.56%
NASDAQ 5,102.2510 +13.0450 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs